Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
AK130
/
Akesobio
Welcome,
Profile
Billing
Logout
Diseases
Trials
Trials
News
|||
|||||||
AK130
/
Akesobio
New P1 trial, Metastases:
A Study of AK130 in Patients With Advanced Malignant Tumors
(clinicaltrials.gov) - Dec 16, 2022
P1
, N=72, Not yet recruiting,
Sponsor: Akeso